Subscribe and receive updates on this company

Text STOCKS to 72727 for mobile alerts

We are excited to present BlackRock Health Sciences Trust (NYSE: BME).

Full DD Report for BME

You must become a subscriber to view this report.

Recent News from (NYSE: BME)

Closed-End Fund BME - Another Way To Play The Healthcare Sector
I recently published an article about Tekla Healthcare Opportunities Fund (THQ), " Closed-End Fund THQ - Large-Cap Healthcare Stocks At An 8% Yield " looking at THQ as a potential play on a healthcare rebound. If you are interested in the healthcare sector but not sure which name to buy as an ...
Source: SeekingAlpha
Date: April, 21 2018 09:52
The Chemist's CEF Report - March 2018: CEFs Not Overreacting To Market Volatility
For the inaugural issue of The Chemist's CEF Report (September 2016), describing the background and rationale of the Report, please click here . This edition uses data taken from the close of March 1. Previous editions of the Report can be searched using the keyword "cefrep". Methodology...
Source: SeekingAlpha
Date: April, 04 2018 16:34
Healthcare sector in the red premarket on Trump/Xi tariff tit-for-tat
Healthcare stocks are poised for a gap down at the open on the heels of a growing trade war between the U.S. and China. The Trump administration recently instituted 25% tariffs on certain Chinese imports and China responded with its own 25% tariffs on 106 American goods, a classic tit-for-ta...
Source: SeekingAlpha
Date: April, 04 2018 07:59
Billions on the line as White House and insurers wait for appeals court decision on ACA payments
The Trump administration and health insurers are awaiting a decision from three-judge panel at the U.S. Court for Appeals for the Federal Circuit related to disputed payments owed insurers from the Obama administration. More news on: ProShares Ultra Nasdaq Biotechnology ETF, The Gabelli ...
Source: SeekingAlpha
Date: March, 15 2018 15:59
The Chemist's CEF Report - February 2018: Rate Worries Stifle Fixed Income CEFs
For the inaugural issue of The Chemist's CEF Report (September 2016), describing the background and rationale of the Report, please click here . This edition uses data taken from the close of January 30. Previous editions of the Report can be searched using the keyword "cefrep". Methodol...
Source: SeekingAlpha
Date: March, 05 2018 14:41
February: Contrarian Closed-End Funds Opportunities Abound
The strength of January disappeared in February despite little negative macroeconomic news, leading many analysts to conclude that profit-taking (and to a certain extend deleveraging) was driving the sudden fall in the S&P 500 ( SPY ). And while the shot-up in the VIX drove a fascinating, ...
Source: SeekingAlpha
Date: March, 03 2018 23:15
Berkshire-Amazon-JPMorgan healthcare venture more than just pricing power - Buffett
In an interview with CNBC, Warren Buffett said the healthcare joint venture between Berkshire, Amazon and JPMorgan is "far more ambitious" than just leveraging negotiating strength to shave 3 - 4% off costs. Its goal is to deliver better care for less money, an objective that he cautions w...
Source: SeekingAlpha
Date: February, 26 2018 13:21
HHS debuts new rule allowing increased access to short-term insurance plans
The Trump administration has released a new rule that will allow Americans greater access to short-term health insurance plans, specifically allowing people to buy health insurance coverage for up to one year. More news on: Aetna, Inc., Cigna Corp., UnitedHealth Group Inc., Healthcare st...
Source: SeekingAlpha
Date: February, 20 2018 13:16
BlackRock funds goes ex-dividend tomorrow
BlackRock Resources and Commodities Strategy Trust (NYSE: BCX ) - $0.0516. BlackRock Enhanced Equity Dividend Trust (NYSE: BDJ ) - $0.0467. BlackRock Energy and Resources Trust (NYSE: BGR ) - $0.0776. BlackRock International Growth and Income Trust (NYSE: BGY ) - $0.0380. BlackRock H...
Source: SeekingAlpha
Date: February, 13 2018 08:09
Will healthcare stocks hold steady amidst broad selloff?
U.S. stock index futures point to another down day today. So far, the only large cap healthcare issue in the red premarket is AbbVie (NYSE: ABBV ), down  3%  but on light volume. More news on: AbbVie Inc., ProShares Ultra Nasdaq Biotechnology ETF, The Gabelli Healthcare & Wel...
Source: SeekingAlpha
Date: February, 05 2018 06:57


About BlackRock Health Sciences Trust (NYSE: BME)

Logo for BlackRock Health Sciences Trust (NYSE: BME)

Not available


Contact Information



Current Management

  • Robert S. Kapito / CEO
  • Donald C. Burke / CFO

Current Share Structure


    Recent Filings from (NYSE: BME)

    Definitive materials filed by investment companies
    Filing Type: 497Filing Source: edgar
    Filing Date: April, 30 2018
    Amendment to Registration statement for management investment companies
    Filing Type: 486BPOSFiling Source: edgar
    Filing Date: April, 27 2018



    Daily Technical Chart for (NYSE: BME)

    Daily Technical Chart for (NYSE: BME)

    Stay tuned for daily updates and more on (NYSE: BME)

    It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

    More to come on (NYSE: BME)

    Do your DD and if you choose, be ready to go!


    The Research: All source information contained in this email is from the public sources mentioned below.



    Thank you

    OTC Report



    Disclaimer: OTC Report publishes reports providing information on selected companies. OTC Report is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. OTC Report accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in BME is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. OTC Report has received up to $100,000 worth of crypto currency from a non-affiliated third party for the publication and circulation of this report. OTC Report does not own any shares of BME and does not buy, sell, or trade any shares of BME. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by OTC Report. All rights reserved. Our Full Disclaimer: